Mounjaro® KwikPen (tirzepatide) is an innovative injectable weight loss drug. It mimics natural GLP-1 and GIP hormones in your gut, helping you control your appetite and making you feel fuller for longer. When paired with a reduced-calorie diet and increased physical activity, it results in effective, healthy weight loss.
Mounjaro® is an injectable medication that comes in a pre-filled pen. It needs to be used once weekly, on the same day. The pen itself is simple to use and the needles are very small, so it’s relatively pain-free and easy to get used to.
Mounjaro® can be injected in the abdomen, thigh or upper arm at any time during the day, with or without food. It’s recommended that you use it around the same time each week — this will regulate the medication’s effectiveness.
You’ll receive clear instructions with your first order on the specifics for applying your treatment confidently. Our team are also on hand to answer any questions.
Mounjaro® (tirzepatide) is an injectable weight loss drug for people with a BMI over 30. For individuals with weight related health concerns, they may be eligible with a BMI over 27. These related concerns include high blood pressure, diabetes, heart disease and raised cholesterol.
If you have Type 2 diabetes and a BMI less than 27, we can’t prescribe you Mounjaro® for weight loss.
Your treatment starts at a low dose and then increases every four weeks. When you first start using Mounjaro®, the starting dose is 2.5 mg, once a week, for four weeks. The dose will then be increased after every four weeks until you reach the recommended dose of 15 mg a week.
Mounjaro® is one of the most effective weight loss treatments available. On average, people lose 20.9% body weight over 36 weeks and 25.3% body weight over 88 weeks.
In a study of people with type 2 diabetes on metformin, the active ingredient in Mounjaro® was shown to be twice as effective as Wegovy®.
